Cystectomy in Metastatic Bladder Cancer: Feasibility, Safety and Outcomes.

Background: Potential clinical efficacy of cystectomy in patients with metastatic bladder cancer (mBCa) remains poorly investigated. The clinical data suggest that there could be a benefit from the local treatment in selected patients with mBCa in terms of redeeming local symptoms, increasing quality of life (QoL), and decreasing the number of the potential adverse events of systemic therapy. The aim of our study was to test safety and efficacy of cystectomy in mBCa and its impact on patients' survival, QoL, and eligibility for systemic therapy.